Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Flow cytometry based detection of HLA alloantibody mediated classical complement activation.

Markus Wahrmann1, Markus Exner, Heinz Regele

  • 1Division of Nephrology and Dialysis, Department of Internal Medicine III, University of Vienna, Währinger Gürtel 18-20, A-1090, Vienna, Austria

Journal of Immunological Methods
|April 2, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Highly sensitized kidney transplant candidates: integrating acceptable mismatch, desensitization, imlifidase, and emerging immune-cell targeting strategies.

Frontiers in immunology·2026
Same author

Viewpoint on donor-derived cell-free DNA: context of use and clinical utility are key.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

The Role of Natural Killer Cells in Kidney Transplantation.

Transplantation·2026
Same author

Donor bone marrow together with recipient regulatory T cells induces chimerism without irradiation in kidney transplantation.

Science translational medicine·2026
Same author

Impact of high-altitude exposure on Torque Teno virus and immunosuppression levels in lung transplantation recipients: climbing Mount Jebel Toubkal.

Scientific reports·2026
Same author

Clazakizumab in the treatment of chronic active antibody-mediated kidney transplant rejection: Results from the IMAGINE phase 3, randomized, double-blind, placebo-controlled study.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026

This study introduces a new assay to detect complement activation by HLA alloantibodies using flow cytometry. The novel method reliably identifies complement-fixing antibodies, offering a potential alternative to traditional complement-dependent cytotoxicity testing in transplantation.

Area of Science:

  • Immunology
  • Transplantation Immunology
  • Clinical Chemistry

Background:

  • Complement-dependent cytotoxicity (CDC) panel reactive antibody (PRA) testing is standard for assessing alloantibody formation in transplant recipients.
  • CDC-PRA assays can yield false positives due to autoantibodies or antilymphocyte reagents.
  • Current FlowPRA testing detects HLA alloantibodies but doesn't differentiate between complement-fixing and non-complement-fixing types.

Purpose of the Study:

  • To develop a novel assay for detecting HLA alloantibody-dependent classical complement activation using flow cytometry.
  • To establish a method that distinguishes complement-fixing alloantibodies, which are potentially more harmful.

Main Methods:

  • Developed a flow cytometry-based assay using HLA antigen-coated microbeads (FlowPRA).

Related Experiment Videos

  • Incubated beads with sera from highly sensitized dialysis patients and stained for complement fragments (C4, C3) and C1q deposition.
  • Validated complement activation through C4 inactivation with methylamine and complement-free eluates, assessing temperature-dependent deposition.

    • Main Results:

    • Demonstrated alloantibody-induced deposition of C4 fragments and C1q to HLA beads, confirming classical complement activation.
    • Confirmed de novo complement activation, not preformed complexes, via methylamine treatment and immunoadsorption eluate experiments.
    • Observed temperature-dependent deposition of C4/C1q (max at 4°C) and C3 (max at 37°C, suggesting alternative pathway activation).

    Conclusions:

    • A novel, cell-independent, and user-friendly PRA assay capable of detecting alloantibody-induced classical complement activation via flow cytometry has been developed.
    • This assay shows promise as a potential alternative to CDC-PRA testing in clinical transplantation.
    • Further studies are needed to evaluate its clinical relevance and utility.